SINOPHARM (CNCM LTD) released its performance for the first three quarters, with a net profit attributable to the parent company of 1.492 billion yuan, a year-on-year increase of 0.74%

According to the Zhitong Finance APP, SINOPHARM (CNCM LTD) disclosed its third-quarter report for 2025. In the first three quarters, the company achieved revenue of 39.381 billion yuan, a year-on-year increase of 3.56%; the net profit attributable to shareholders of the listed company was 1.492 billion yuan, a year-on-year increase of 0.74%; the net profit excluding non-recurring items was 1.47 billion yuan, a year-on-year decrease of 1.27%; the basic earnings per share were 1.9778 yuan